Liontrust Investment Partners LLP
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1544204
LONDON, X0
Position in ALNY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$8,055,261
+$2,027,472 QoQ
Shares Held
26,759
+46.9% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#209
of 784 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Liontrust Investment Partners LLP holds $22,762,064 across 3 Biotechnology names. ALNY ranks #2 (35.4% of the industry book) .
All Filings in ALNY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,055,261 | 26,759 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $6,027,789 | 18,218 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $7,311,590 | 18,387 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,315,136 | 11,656 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $4,163,843 | 12,769 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $5,097,977 | 18,880 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,299,752 | 14,023 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,397,977 | 5,083 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,235,169 | 5,083 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $22,417 | 150 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $111,209 | 581 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $171,255 | 967 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,131,696 | 11,223 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,656,433 | 33,229 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $5,710,364 | 28,529 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,904,789 | 33,629 | Shares | Sole | 2022-07-27 | |
| No filing history on record for this holder in this stock. | ||||||